Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies. Issue 2 (February 2020) - Cahn, P.; Madero, J. Sierra; Arribas, J.; Antinori, A.; Ortiz, R.; Clarke, A.; Hung, C.; Rockstroh, J.; Girard, P.; Sievers, J.; Man, C.; Urbaityte, R.; et al.